These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34608550)

  • 21. Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies.
    Kausar N; Ullah S; Khan MA; Zafar H; Atia-Tul-Wahab ; Choudhary MI; Yousuf S
    Bioorg Chem; 2021 Jan; 106():104499. PubMed ID: 33288319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Bis-Schiff's base derivatives of 4-nitroacetophenone as potent α-glucosidase agents: Design, synthesis and in silico approach.
    Alam A; Ali M; Latif A; Rehman NU; Saher S; Zainab ; Faryal ; Khan A; Ullah S; Ullah O; Halim SA; Sani F; Al-Harrasi A; Ahmad M
    Bioorg Chem; 2022 Nov; 128():106058. PubMed ID: 35917750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, In vitro α-Glucosidase Inhibitory Potential and Molecular Docking Studies of 2-Amino-1,3,4-Oxadiazole Derivatives.
    Ullah H; Rahim F; Taha M; Hussain R; Wadood A; Nawaz M; Wahab Z; Kanwal ; Khan KM
    Med Chem; 2020; 16(6):724-734. PubMed ID: 31195948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel (R)-4-fluorophenyl-1H-1,2,3-triazoles: A new class of α-glucosidase inhibitors.
    Avula SK; Khan A; Halim SA; Al-Abri Z; Anwar MU; Al-Rawahi A; Csuk R; Al-Harrasi A
    Bioorg Chem; 2019 Oct; 91():103182. PubMed ID: 31404793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors.
    Gong Z; Xie Z; Qiu J; Wang G
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent α-glucosidase inhibitors.
    Saeedi M; Mohammadi-Khanaposhtani M; Asgari MS; Eghbalnejad N; Imanparast S; Faramarzi MA; Larijani B; Mahdavi M; Akbarzadeh T
    Bioorg Med Chem; 2019 Dec; 27(23):115148. PubMed ID: 31679980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies.
    Asgari MS; Mohammadi-Khanaposhtani M; Sharafi Z; Faramarzi MA; Rastegar H; Nasli Esfahani E; Bandarian F; Ranjbar Rashidi P; Rahimi R; Biglar M; Mahdavi M; Larijani B
    Mol Divers; 2021 May; 25(2):877-888. PubMed ID: 32189236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, in vitro evaluation, and molecular docking studies of novel hydrazineylideneindolinone linked to phenoxymethyl-1,2,3-triazole derivatives as potential α-glucosidase inhibitors.
    Shareghi-Boroujeni D; Iraji A; Mojtabavi S; Faramarzi MA; Akbarzadeh T; Saeedi M
    Bioorg Chem; 2021 Jun; 111():104869. PubMed ID: 33839583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors.
    Nasli Esfahani A; Iraji A; Alamir A; Moradi S; Asgari MS; Hosseini S; Mojtabavi S; Nasli-Esfahani E; Faramarzi MA; Bandarian F; Larijani B; Hamedifar H; Hajimiri MH; Mahdavi M
    Mol Divers; 2022 Aug; 26(4):1995-2009. PubMed ID: 34515954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, in vitro and computational studies of 1,4-disubstituted 1,2,3-triazoles as potential α-glucosidase inhibitors.
    Jabeen F; Shehzadi SA; Fatmi MQ; Shaheen S; Iqbal L; Afza N; Panda SS; Ansari FL
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1029-1038. PubMed ID: 26725952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indane-1,3-diones: As Potential and Selective α-glucosidase Inhibitors, their Synthesis, in vitro and in silico Studies.
    Mukhtar A; Shah S; Kanwal ; Hameed S; Khan KM; Khan SU; Zaib S; Iqbal J; Perveen S
    Med Chem; 2021; 17(8):887-902. PubMed ID: 32851965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel α-glucosidase inhibitors.
    Moghimi S; Salarinejad S; Toolabi M; Firoozpour L; Esmaeil Sadat Ebrahimi S; Safari F; Madani-Qamsari F; Mojtabavi S; Faramarzi MA; Karima S; Pakrad R; Foroumadi A
    Bioorg Chem; 2021 Apr; 109():104670. PubMed ID: 33588241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New carbazole linked 1,2,3-triazoles as highly potent non-sugar α-glucosidase inhibitors.
    Iqbal S; Khan MA; Javaid K; Sadiq R; Fazal-Ur-Rehman S; Choudhary MI; Basha FZ
    Bioorg Chem; 2017 Oct; 74():72-81. PubMed ID: 28756277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, in vitro inhibitor screening, structure-activity relationship, and molecular dynamic simulation studies of novel thioquinoline derivatives as potent α-glucosidase inhibitors.
    Forozan R; Ghomi MK; Iraji A; Montazer MN; Noori M; Dastyafteh N; Mojtabavi S; Faramarzi MA; Sadat-Ebrahimi SE; Larijani B; Javanshir S; Mahdavi M
    Sci Rep; 2023 May; 13(1):7819. PubMed ID: 37188744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies.
    Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A
    Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors.
    Khan IA; Ahmad M; Ashfaq UA; Sultan S; Zaki MEA
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
    Wang G; Wang J; He D; Li X; Li J; Peng Z
    Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
    Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
    Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
    Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.